Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pietschmann

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2017
Immune protection against reinfection with nonprimate hepacivirusStephanie Pfaender, Stephanie Walter, Elena Grabski, et al.
Science Advances|December 6, 2024
Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodiesKumar Nagarathinam, Andreas Scheck, Maurice Labuhn, et al.
Immunity|January 6, 2022
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralizationTimm Weber, Julian Potthoff, Sven Bizu, et al.
Journal of Virology|November 1, 2019
Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated VirolysisHans Prochnow, Katharina Rox, N V Suryanarayana Birudukota, et al.
Hepatology (Baltimore, Md.)|August 8, 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1Paula M Perin, Sibylle Haid, Richard J P Brown, et al.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2025
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the KidneyAvista Wahid, Nele Meyer, Christine Wundes, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2025
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variantsToni Luise Meister, Maximilian K Nocke, Natalie Heinen, et al.
Nature Communications|February 26, 2025
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric miceGeorge Ssebyatika, Katja Dinkelborg, Luisa J Ströh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 27, 2025
Acute respiratory tract infections during the first 6 years of life - results from the German birth cohort study LoewenKIDSBianca Klee, Sophie Diexer, Susan Langer, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2017
Immune protection against reinfection with nonprimate hepacivirusStephanie Pfaender, Stephanie Walter, Elena Grabski, et al.
Science Advances|December 6, 2024
Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodiesKumar Nagarathinam, Andreas Scheck, Maurice Labuhn, et al.
Immunity|January 6, 2022
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralizationTimm Weber, Julian Potthoff, Sven Bizu, et al.
Journal of Virology|November 1, 2019
Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated VirolysisHans Prochnow, Katharina Rox, N V Suryanarayana Birudukota, et al.
Hepatology (Baltimore, Md.)|August 8, 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1Paula M Perin, Sibylle Haid, Richard J P Brown, et al.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2025
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the KidneyAvista Wahid, Nele Meyer, Christine Wundes, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2025
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variantsToni Luise Meister, Maximilian K Nocke, Natalie Heinen, et al.
Nature Communications|February 26, 2025
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric miceGeorge Ssebyatika, Katja Dinkelborg, Luisa J Ströh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 27, 2025
Acute respiratory tract infections during the first 6 years of life - results from the German birth cohort study LoewenKIDSBianca Klee, Sophie Diexer, Susan Langer, et al.
Pageof 21